A phase I, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study evlauating the pharmacokinetics, pharmacodynamics, and tolerability of verinurad in healthy adult males

Trial Profile

A phase I, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study evlauating the pharmacokinetics, pharmacodynamics, and tolerability of verinurad in healthy adult males

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Verinurad (Primary)
  • Indications Gout; Hyperuricaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
    • 25 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top